A new link between high levels of certain amino acids and type 2 diabetes has been found by a team of scientists, using mouse and human muscle and blood samples to evaluate the mechanisms that lead to insulin resistance. The findings of this study appear online in Nature Medicine ahead of the print issue.

For people with type 2 diabetes, the problem of insulin resistance means there is plenty of insulin but the body does not respond to it effectively. Diabetes is also a problem with excess fat, especially too much fat inside skeletal muscle, which leads to the insulin resistance. In short, if the level of fat in muscles can be reduced then, theoretically, insulin resistance can be prevented.

"This research sought to answer a few large questions," said senior author Zoltan Arany, MD, PhD, an associate professor of Cardiovascular Medicine. "How does fat get into skeletal muscle? And how is the elevation of certain amino acids in people with diabetes related to insulin resistance? We have appreciated for over ten years that diabetes is accompanied by elevations in the blood of branched-chain amino acids, which humans can only obtain in their diet. However, we didn't understand how this could cause insulin resistance and diabetes. How is elevated blood sugar related to these amino acids?"

The team found that a byproduct compound of breakdown of these amino acids, called 3-HIB, is secreted from muscle cells and activates cells in the vascular wall to transport more fat into skeletal muscle tissue. This leads to fat accumulation in the muscle, in turn leading to insulin resistance in mice. Conversely, inhibiting the synthesis of 3-HIB in muscle cells blocked the uptake of fat in muscle.

While most of this research was conducted using mouse cells, the team also found that 3-HIB, the byproduct molecule, was elevated in people with type 2 diabetes. Because of this, Arany and colleagues say that more studies are needed to fully examine the nature of this mechanism among people with type 2 diabetes. "The discovery of this novel pathway -- the way the body breaks down these amino acids that drives more fat into the muscles -- opens new avenues for future research on insulin resistance, and introduces a conceptually entirely new way to target treatment for diabetes" Arany said.

Read More